Edmond De Rothschild Holding S.A. Denali Therapeutics Inc. Transaction History
Edmond De Rothschild Holding S.A.
- $6.04 Billion
- Q3 2024
A detailed history of Edmond De Rothschild Holding S.A. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 205,680 shares of DNLI stock, worth $4.78 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
205,680
Previous 205,680
-0.0%
Holding current value
$4.78 Million
Previous $4.78 Million
25.47%
% of portfolio
0.1%
Previous 0.08%
Shares
7 transactions
Others Institutions Holding DNLI
# of Institutions
228Shares Held
120MCall Options Held
60.6KPut Options Held
48.4K-
Baillie Gifford & CO13.3MShares$310 Million0.3% of portfolio
-
Black Rock Inc. New York, NY13.2MShares$306 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$260 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$249 Million0.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.91MShares$184 Million0.05% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $3.12B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...